Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-05-04, Stock:JNJ, The news for the past five days is as follows:
2021-04-27: NEWS1: Bayou Intermediate II, LLC -- Moody's assigns a B2 CFR to Bayou Intermediate II, LLC; outlook stable.NEWS2: Top Pharma Giants Expected to Be Most Active in M&A.NEWS3: CDC’s latest guidance on outdoor mask wearing ‘is a big milestone’: Doctor.NEWS4: CDC: Small groups of people can gather outside without masks.NEWS5: India’s COVID surge is ‘beyond heartbreaking,’ says WHO director-general, as first relief supplies arrive.NEWS6: U.S. probing two new blood clot cases after J&J's COVID-19 vaccine.NEWS7: 3 Dividend Stocks That Just Hiked Their Payouts.NEWS8: This Pharma Giant Lost the Vaccine Race, But Its COVID-19 Journey May Not Be Over.NEWS9: Is There Any Hope Left for Emergent BioSolutions?.NEWS10: 3 Reasons Not to Buy Johnson & Johnson Stock Just Because Its COVID Vaccine Pause Was Lifted.NEWS11: Is There Any Hope for Inovio?.NEWS12: California man hospitalized with blood clot after J&J vaccination.
2021-04-28: NEWS1: Streaming TV, Burritos, Beer, and Capital Gains Taxes.NEWS2: Starbucks CEO: Vaccines and the 'great human reconnection' create a 2- to 3-year tailwind.NEWS3: It’s ‘good to lift’ COVID-19 restrictions right now: UAB Epidemiologist .NEWS4: 3 Top Healthcare Stocks to Buy and Hold for the Next 10 Years.NEWS5: Strong New Drugs Sales to Aid AbbVie's (ABBV) Q1 Earnings.NEWS6: Vaccinated Americans 'can now enjoy some more freedoms,' health expert explains.
2021-04-29: NEWS1: UPDATE 2-Emergent hopes to answer U.S. FDA on Baltimore plant within days.NEWS2: Dr. Krutika Kuppalli explains why COVID-19 cases could get worse in India before improving.NEWS3: Moderna ramps up investments to triple vaccine output, eyes boosters.NEWS4: NYC reopening timeline is a ‘disastrous issue’: Doctor.NEWS5: Doctor: Travel ban from India to the U.S. could be 'counterproductive'.NEWS6: 7 Reasons to Invest in Dividend-Paying Stocks for Retirement.NEWS7: Better Buy: Johnson & Johnson Stock or the Entire S&P 500?.NEWS8: Is Novavax Stock A Buy On Hints Its Covid Vaccine Is Nearing Authorization?.NEWS9: Spain's Reig Jofre new plant to produce J&J vaccine by end-Q2.
2021-04-30: NEWS1: 'Things are going to get much worse before they get better' in India: Expert.NEWS2: West Virginia Governor on offering incentives after state ‘hit a wall’ in vaccinations.NEWS3: Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg.NEWS4: West Virginia city takes big three drug distributors to court over opioids.NEWS5: California has lowest COVID-19 case rate in the U.S.: RPT.NEWS6: Pharma Stock Roundup: Big Drugmakers' Q1 Earnings, Resumption of JNJ US COVID-19 Jabs.NEWS7: Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days.NEWS8: South Africa regulator says J&J shot can be given to pregnant women.NEWS9: Emergent (EBS) Beats on Q1 Earnings, Cuts Contract Revenue View.
2021-05-03: NEWS1: AbbVie's Humira Still Number 1 in Drug Sales.NEWS2: Vaccine Hesitancy Ticks Down — Here's What That Means For Covid Stocks.NEWS3: A ‘one size fits all policy’ for reopening travel is very concerning: Doctor.NEWS4: Denmark says it won't use J&J COVID vaccine due to blood-clotting concerns.NEWS5: People should focus on wearing masks indoors 'where it matters the most': Doctor.NEWS6: COVID-19 latest: U.S. cases fall, EU looks to reopen, India cases on the rise.NEWS7: UPDATE 2-Denmark ditches J&J COVID-19 shots from vaccination programme.NEWS8: UPDATE 4-Big three drug distributors blame doctors, regulators in trial over opioid epidemic.NEWS9: 3 Big Drugmaker Stocks to Watch Out For Amid Pandemic Woes.NEWS10: Eupraxia Pharmaceuticals Inc. Announces Appointment of Bruce Cousins as President & CFO.NEWS11: The Zacks Analyst Blog Highlights: Eli Lilly, Merck, GlaxoSmithKline, Novartis and Johnson & Johnson.NEWS12: Drug distributors face off against West Virginia in billion-dollar opioid trial.NEWS13: Denmark drops J&J Covid vaccine over blood clot concerns.

Answer: Rise